{"id":818987,"date":"2025-02-27T07:10:11","date_gmt":"2025-02-27T12:10:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/"},"modified":"2025-02-27T07:10:11","modified_gmt":"2025-02-27T12:10:11","slug":"beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/","title":{"rendered":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>IRVINE, Calif., Feb.  27, 2025  (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to review the company\u2019s fourth quarter and full year 2024 performance.<\/p>\n<p>The link to the webcast will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uZoW4jnaYSYYmIEJtwNNZxV-z9gkKF0kky415OY01Q8oMOp0MHunO67-lSJLs1U8OvCRzuaNCe3avcZz_RxtEnNpZnU7VP02QdNkhtS-tKx-PUFa8YIbQYSlipuEhPB_\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.betabionics.com<\/a>, and will be archived there for future replay. To access the live call by phone, please use the following link, which will provide you with dial-in details and a personal pin: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uZoW4jnaYSYYmIEJtwNNZ8BY8OM7_zf95D7jQDlkmurcaSY8-_8v8Burcj-2Va9cQPzPzrivkijpOIsZt15fJnq0TFH2e26RiaDFNd3xRKhUx9iBfLooySoJXzHw0MSR2TmwX5dk34m2_uWWmLpFbRWOi6FVi-N0jy4w6yHLAWNnqCKi4bkx_RKidxrxzuUcupQFhx66OFc0rNQpnhv_CuyAUrnBGV33ef3H9ZDglQQYDFlHC1C4SsTc1ZEUJsCK\" rel=\"nofollow\" target=\"_blank\">https:\/\/register-conf.media-server.com\/register\/BI8be51a4e688845529dd55d442f427c91<\/a>.<\/p>\n<p>\n        <strong>About Beta Bionics<\/strong>\n      <\/p>\n<p>Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oWxjC75SIdBSNd4nGHPT8--wWod0Drv4_WIhO1M1XZl4wmvEGh1myUHTuywtGhVZMoW7KWjapQ1uo4zKfGe_ppce1NwSsxJz0_UQ8gzT_I4=\" rel=\"nofollow\" target=\"_blank\">www.betabionics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Blake Beber<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MuCTUwG8zYwC6XiLc4eafKRah13F7HXF6LLogBK0bbCqq-K7rhPc28jib5ooPALKCXDIBaKvla4akeb0CdQNyDF02t_TQoUdlxrC2pdGL78=\" rel=\"nofollow\" target=\"_blank\"><strong>ir@betabionics.com<\/strong><\/a><\/p>\n<p>\n        <strong>Media and Public Relations<\/strong>: <br \/>Karen Hynes<br \/>Vice President of Marketing<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c_859uEJglMa4F1yv1Tbxk_UMLnIvBf5YPZc7gZHZWaBMn8_Gs87XRah690-p_uDbgnef02OFgGYaAbCzxh9OD0MOARGhc3U7nHjZarptiw=\" rel=\"nofollow\" target=\"_blank\"><strong>media@betabionics.com<\/strong><\/a><\/p>\n<p>Source:\u00a0Beta Bionics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjI0NDY1MmYtY2FhZS00ZDUwLTkxNzctYmNjYzBjMGRjYjYyLTEyMTg5NDk=\/tiny\/Beta-Bionics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to review the company\u2019s fourth quarter and full year 2024 performance. The link to the webcast will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at https:\/\/investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-818987","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to review the company\u2019s fourth quarter and full year 2024 performance. The link to the webcast will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at https:\/\/investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use &hellip; Continue reading &quot;Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-27T12:10:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025\",\"datePublished\":\"2025-02-27T12:10:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/\",\"name\":\"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=\",\"datePublished\":\"2025-02-27T12:10:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/","og_locale":"en_US","og_type":"article","og_title":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Market Newsdesk","og_description":"IRVINE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to review the company\u2019s fourth quarter and full year 2024 performance. The link to the webcast will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at https:\/\/investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use &hellip; Continue reading \"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-27T12:10:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025","datePublished":"2025-02-27T12:10:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/","name":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=","datePublished":"2025-02-27T12:10:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTU1NCM2NzgxMDI1IzIyMDczOTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-25-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/818987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=818987"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/818987\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=818987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=818987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=818987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}